Optimal Therapeutics Announces the Signing of a Licensing Agreement with Kwowa Hakko USA for the Ingredient Cognizin(R) to be Included in Their Brain Function Formula Neurovar

Author: Optimal Therapeutics
Dateline: Mon, 21 Mar 2005

freeNewsArticles Story Summary: “CEDAR GROVE, NJ /Send2Press Newswire/ -- Optimal Therapeutics announces the signing of a licensing agreement with Kwowa Hakko USA for the ingredient Cognizin(R) to be included in their brain function formula Neurovar.”



A R T I C L E:

CEDAR GROVE, NJ /Send2Press Newswire/ -- Optimal Therapeutics announces the signing of a licensing agreement with Kwowa Hakko USA for the ingredient Cognizin(R) to be included in their brain function formula Neurovar.

Optimal Therapeutics company spokesperson Camille Westhoff states "Cognizin(R) is an exciting ingredient that immediately places the Neurovar formulation at the top in this competitive class."

Neurovar also contains other quality ingredients like Phosphatidyl Serine, Bacopa Monniera, Alpha GPC, Ginkgo Biloba, Vinpocetine and Acetyl-L-Carnitine.

Optimal Therapeutics, a Neutraceutical manufacturer based in New Jersey, also produces Zyroxin, Zalestra, Phosoplex, Fematril, Viastat amongst other quality formulations. Optimal Therapeutics products can be found online at www.BodEStore.com and at Amazon.

###


Copyright © 2005 by Optimal Therapeutics and Send2Press® Newswire, a service of Neotrope® - all rights reserved. Information believed accurate but not guaranteed. Sourced on: freeNewsArticles.com.

Story Title: Optimal Therapeutics Announces the Signing of a Licensing Agreement with Kwowa Hakko USA for the Ingredient Cognizin(R) to be Included in Their Brain Function Formula Neurovar
• REFERENCE KEYWORDS/TERMS: , , , , Health, Diet and Fitness, , , .

IMPORTANT NOTICE: some content which is considered "old" or "archival" may reference an event which has already occurred; some content possibly considered "advertorial" may also reference a promotion or time-limited/sensitive offering, and in all of these instances certain material may no longer be valid. For notably stale content, you should directly contact the company/person mentioned in the text (Optimal Therapeutics); this site cannot assist you with information about products/services mentioned in the news article, nor handle any complaints or other issues related to any person/company mentioned or promoted in the above text. Information believed accurate but not guaranteed as of original date of story [Mon, 21 Mar 2005 20:25:00 GMT].

USE THIS CONTENT FOR FREE: To use this content in your newspaper, broadcast outlet, news portal, blog/ezine or similar, free of cost, CLICK HERE to learn how.